Am J Transplant, Volume 19, Suppl 3 Archives - Page 185 of 214 - ATC Abstracts

2019 American Transplant Congress
Impact of Ureteral Stent on Urinary Tract Complications after Deceased Donor Renal Transplantation
L. Zheng, H. Jia, H. Chen, J. Wu
Kidney disease center, The First Affiliated Hospital, College Of Medicine,Zhejiang University, Hangzhou, China
*Purpose: Urinary tract complications after renal transplantation, including urinary mechanical and infectious complications, could lead to graft loss. In order to avoid these situations, prophylactic…
2019 American Transplant Congress
Urinary Microtubule-Associated Protein Light Chain3 and Neutrophil Gelatinase-Associated Lipocalin, as Potential Noninvasive Biomarkers for Subclinical Rejection at 3 Months after Kidney Transplantation
S. Tajima¹, R. Fu², M. Fukuda², K. Suetsugu², Y. Okabe³, S. Masuda¹
¹Pharmacy, Kyushu University Hospital, Fukuoka, Japan, ²Clinical Pharmacology and Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan, ³Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
*Purpose: Biopsy proven acute rejection without clinical symptoms such as subclinical rejection (SCR) is supposed to associate graft loss in the long term post kidney…
2019 American Transplant Congress
The Impact of Early Subtherapeutic Tacrolimus Troughs with Alemtuzumab Induction
L. Bowman¹, E. Yanqui¹, C. Truong¹, R. Baliga², A. Brueckner¹
¹Tampa General Hospital, Tampa, FL, ²Florida Kidney Physicians, Tampa, FL
*Purpose: Prior studies in kidney transplant recipients (KTR) have demonstrated that lower tacrolimus (TAC) exposure during the first week is associated with an increased incidence…
2019 American Transplant Congress
Effect of Severe Diarrhea on Kidney Transplant Outcomes
J. Kim, J. Ha, Y. Kim, S. Han
Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: In addition to immunological complications, non-immunological events should be considered following kidney transplantation. Among them, diarrhea is the most common gastrointestinal complication, but its…
2019 American Transplant Congress
Rituximab Protects against Development of Atherosclerotic Cardiovascular Disease after Kidney Transplantation, a Propensity Matched Analysis
D. Kim, J. Lee, J. Lee, B. Kim, M. Kim, S. Soon Il, Y. Kim, K. Huh, S. Kim, D. Joo, K. In, E. Kim
Severance hospital, Seoul, Korea, Republic of
*Purpose: Recent studies have implicated B cells in atherosclerosis and have verified the atheroprotective effect of rituximab. We sought to explore the effects of rituximab…
2019 American Transplant Congress
Growth and Function of En Bloc Kidney Transplantation: A Single-Center Experience
H. Mo¹, J. Ha¹, A. Han¹, S. Min¹, S. Min¹, S. Ahn¹, I. Ha², H. Kang², S. Kim³
¹Department of surgery, Seoul National University Hospital, Seoul, Korea, Republic of, ²Pediatric Nephrology, Seoul National University Hospital, Seoul, Korea, Republic of, ³Department of surgery, Myongji Hospital, Seoul, Korea, Republic of
*Purpose: To overcome organ shortage, using en bloc renal allografts is widely accepted strategy. In this study we review the results of en bloc kidney…
2019 American Transplant Congress
The Response to Human Papillomavirus Vaccination in Pediatric Patients before and after Kidney Transplantation
C. Nailescu¹, R. D. Nelson², K. Twombley³, P. S. Verghese⁴, A. S. Chishti⁵, M. Mills⁶, J. E. Slaven⁷, J. D. Mahan⁸, M. L. Shew¹
¹Riley Hospital for Children, Indianapolis, IN, ²Primary Children’s Hospital, Salt Lake City, UT, ³MUSC Children’s Hospital, Charleston, SC, ⁴Children’s Hospitals and Clinics of Minnesota, Minneapolis, MN, ⁵Kentucky Children’s Hospital, Lexington, KY, ⁶C.S. Mott Children’s Hospital, Ann Arbor, MI, ⁷Indiana University, Indianapolis, IN, ⁸Nationwide Children’s Hospital, Columbus, OH
*Purpose: Kidney transplant (KT) recipients have an increased incidence of malignancies, including Human Papillomavirus (HPV)-associated cancers. Thus, HPV vaccines may have an important role in…
2019 American Transplant Congress
Immunosuppression Reduction after Diagnosis of Sustained BK Viremia and the Risk of Allograft Rejection, Allograft Loss and Mortality
F. A. Al Dhufairi¹, M. Shokoohi², A. M. Jevnikar¹, A. A. House¹, D. Kumar³, S. M. Hosseini-Moghaddam¹
¹Department of Medicine, Western University, London Health Sciences Centre, London, ON, Canada, ²Epidemiology and Biostatistics, Western University, London, ON, Canada, ³Department of Medicine, University Of Toronto, University Health Network, Toronto, ON, Canada
*Purpose: BK viremia increases the risk of allograft loss after renal transplantation. Current guidelines recommend immunosuppression reduction (IsR) after the diagnosis of BK viremia. The…
2019 American Transplant Congress
BK Virus Infection among Kidney Transplant Recipients with High Immunological Risk and Strong Immunosupression
G. Ledesma, M. O. Lopez, G. Carreño, M. J. Santana, M. A. Vaca, E. Gonzalez, C. Jimenez
Nephrology, Hospital Universitario La Paz, Madrid, Spain
*Purpose: BK virus infection represents one of the main viral infections within the first year after kidney transplantation, closely linked to the degree of immunosupresion.…
2019 American Transplant Congress
Identifying a Clinically Relevant Cut-Off for Height That is Associated with a Higher Risk of Waitlist Mortality in Liver Transplant Candidates
J. Ge, J. C. Lai
University of California - San Francisco, San Francisco, CA
*Purpose: We have previously demonstrated that candidate height explains a substantial proportion of sex-based disparity in waitlist (WL) mortality among liver transplant (LT) candidates. To…